Angeles Alvarez Secord
9PUBLICATIONS
96CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (9)
Sort by Publication Date:
|Dec 11, 2025
Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.Robert L Hollis, Austin Miller, Heather A Lankes
|Sep 03, 2025
Suppression of Paclitaxel-Induced Neuropathy and Ovarian Tumor Growth by Mn Porphyrin, MnTnBuOE-2-PyP5+ (BMX-001).Ivan Spasojevic, Zhiqing Huang, Welida Tamires Alves da Silva
|Oct 03, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.Jung-Min Lee, Mark F Brady, Austin Miller
|Oct 31, 2023
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018).Rebecca C Arend, Bradley J Monk, Ronnie Shapira-Frommer
|Jun 06, 2022
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.Kristina W Thiel, Eric J Devor, Virginia L Filiaci
Pageof 2
Frequent Collaborators
3 joint publications
Krishnansu S Tewari
3 joint publications
Austin Miller
2 joint publications
Matthew Powell
2 joint publications
Virginia L Filiaci
2 joint publications
Kathleen N Moore
2 joint publications
David Mutch
2 joint publications
Huaxin Sheng
2 joint publications
Ines Batinic-Haberle
2 joint publications
Artak Tovmasyan
2 joint publications
Weina Duan